Benioff 10b5-1 Plan: 2,250 Options Exercised and Shares Sold at ~$243–$247
Rhea-AI Filing Summary
Marc Benioff, Chair and CEO of Salesforce, reported transactions on Form 4 showing activity on 09/19/2025 executed under a Rule 10b5-1 trading plan adopted January 9, 2025. He exercised 2,250 non-qualified stock options with an exercise price of $161.50 and immediately acquired 2,250 shares. On the same date he sold a total of 2,250 common shares in multiple transactions at weighted average prices ranging from $243.49 to $247.19, producing weighted-average sale prices listed by lot. Following these transactions, he directly beneficially owns 11,911,571–11,913,821 shares across direct and trust holdings and indirectly holds 10,107,000 shares via trusts and Marc Benioff Fund LLC.
Positive
- Transactions were executed under a Rule 10b5-1 plan, indicating pre-arranged trades and reducing concerns about opportunistic insider trading
- Clear disclosure of direct and indirect holdings, including trusts and Marc Benioff Fund LLC, improving transparency
Negative
- Insider sales totaling 2,250 shares were reported on the same date as an option exercise, which represents executive liquidity
- Weighted-average sale prices span a wide range ($243.49–$247.19), with per-lot sale counts not detailed in the filing (offered on request)
Insights
TL;DR: Routine option exercise and coordinated share sales under a 10b5-1 plan; transparency maintained through disclosures.
The filing documents an option exercise and contemporaneous share sales executed pursuant to a pre-established Rule 10b5-1 trading plan, which is commonly used by executives to avoid impermissible insider trading. The report includes weighted-average sale prices across multiple trade lots and details of direct and indirect holdings, including trust and LLC ownership. For governance, the presence of a 10b5-1 plan and clear disclosure of indirect holdings enhances transparency, though investors may note insider selling volume relative to total holdings.
TL;DR: Option exercise at $161.50 followed by matched share sales at ~$243–$247; net share count remains large.
From a securities perspective, the exercise of 2,250 options at $161.50 created an immediate non-derivative position that was subsequently sold in multiple tranches at weighted-average prices between $243.49 and $247.19. The filing quantifies both direct and indirect beneficial ownership across trusts and an LLC, and the reporter offers to provide exact per-lot sale counts on request. This is a routine executive liquidity event documented under a 10b5-1 plan; it does not by itself disclose company performance metrics.